Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732140) titled 'Listen Aphasia Pilot Study' on July 23.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Dana-Farber Cancer Institute
Condition:
Aphasia
Malignant Brain Tumor
Intervention:
Device: LISTEN (AI-based AAC smartphone app)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 2027
Target Sample Size: 80
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07732140
Disclaimer: Curated by HT Syndica...